Kadcyla Halves Tumor Recurrence for Women With a Common Breast Cancer
WEDNESDAY, Dec. 5, 2018 -- For certain women with early stage breast cancer, a newer drug that combines an antibody with chemotherapy may cut the risk of disease recurrence in half, a new trial finds.
The study focused on nearly 1,500 women with...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | General Medicine | Study | Women